scholarly article | Q13442814 |
P50 | author | Pär Matsson | Q37386218 |
Sook Wah Yee | Q80541004 | ||
P2093 | author name string | K M Giacomini | |
E Jorgenson | |||
G Jenkins | |||
D L Kroetz | |||
J Xuan | |||
S Markova | |||
K Morrissey | |||
P2860 | cites work | Genome-wide associations of gene expression variation in humans | Q21145274 |
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis | Q22004274 | ||
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency | Q22010457 | ||
Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association | Q22306345 | ||
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters | Q24290568 | ||
ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins | Q24306627 | ||
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters | Q24308754 | ||
Phosphatidylcholine translocase: a physiological role for the mdr2 gene | Q24319732 | ||
Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption | Q24539051 | ||
Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region | Q24560017 | ||
A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern | Q24567552 | ||
Common genetic variants account for differences in gene expression among ethnic groups | Q24626446 | ||
Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci | Q24631841 | ||
Genome-wide identification of DNaseI hypersensitive sites using active chromatin sequence libraries | Q24633720 | ||
Ultraconservation identifies a small subset of extremely constrained developmental enhancers | Q24648269 | ||
Altered expression of ALDP in X-linked adrenoleukodystrophy | Q24671055 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport | Q24678486 | ||
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias | Q27860710 | ||
Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome | Q28131828 | ||
Scanning Human Gene Deserts for Long-Range Enhancers | Q28210571 | ||
Genetic structure of human populations | Q28218564 | ||
ChIP-seq accurately predicts tissue-specific activity of enhancers | Q28235102 | ||
High-resolution mapping and characterization of open chromatin across the genome | Q28266995 | ||
Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel | Q28272300 | ||
The role of ABC transporters in drug resistance, metabolism and toxicity | Q28283237 | ||
Genomic maps and comparative analysis of histone modifications in human and mouse | Q29614418 | ||
A genome-wide association study of global gene expression | Q29614592 | ||
Population genomics of human gene expression | Q29614905 | ||
In vivo enhancer analysis of human conserved non-coding sequences | Q29616554 | ||
Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. | Q31942201 | ||
High-resolution mapping of expression-QTLs yields insight into human gene regulation | Q33375030 | ||
Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines | Q34288272 | ||
Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice | Q34913579 | ||
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. | Q35048738 | ||
DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis | Q35248559 | ||
The MRP family of drug efflux pumps | Q35567296 | ||
Gene-expression variation within and among human populations | Q35677775 | ||
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach | Q35946327 | ||
Evaluation of genetic variation contributing to differences in gene expression between populations | Q36718956 | ||
Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5). | Q37162177 | ||
Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population | Q37591896 | ||
Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy | Q37737633 | ||
Comment on "Genetic structure of human populations". | Q38996711 | ||
ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer | Q39905259 | ||
Catalytic site modifications of TAP1 and TAP2 and their functional consequences. | Q40215001 | ||
Metrics of sequence constraint overlook regulatory sequences in an exhaustive analysis at phox2b | Q42239743 | ||
Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2). | Q43127132 | ||
When good drugs go bad. | Q45975464 | ||
Japan Arteriosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC): rationale, design, and population characteristics | Q46410488 | ||
Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels. | Q46805420 | ||
Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. | Q52519846 | ||
Qualifying the relationship between sequence conservation and molecular function | Q80620353 | ||
The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies | Q81612489 | ||
P433 | issue | 3 | |
P921 | main subject | quantitative trait | Q112670498 |
trait mapping | Q117704033 | ||
P304 | page(s) | 214-226 | |
P577 | publication date | 2011-03-08 | |
P1433 | published in | The Pharmacogenomics Journal | Q10534704 |
P1476 | title | Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping | |
P478 | volume | 12 |
Q34360091 | ABCD2 alters peroxisome proliferator-activated receptor α signaling in vitro, but does not impair responses to fenofibrate therapy in a mouse model of diet-induced obesity |
Q46418563 | ABCG2 regulatory single-nucleotide polymorphisms alter in vivo enhancer activity and expression |
Q38884180 | Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant |
Q89890455 | Genetic Diversity in Drug Transporters: Impact in African Populations |
Q38730592 | In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus |
Q35799841 | Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation |
Q38629883 | Pharmacogenomics considerations in the control of hypertension |
Q27025558 | Pharmacogenomics of chemotherapeutic susceptibility and toxicity |
Q36252524 | Relating human genetic variation to variation in drug responses |
Q96953681 | Statin Use Associates With Risk of Type 2 Diabetes via Epigenetic Patterns at ABCG1 |
Q36203536 | The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. |